Canada markets closed

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.4400+0.0400 (+1.67%)
At close: 08:05AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 6.26B
Enterprise Value 5.48B
Trailing P/E 7.38
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.39
Price/Book (mrq)0.82
Enterprise Value/Revenue 0.54
Enterprise Value/EBITDA 7.40

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3-10.29%
S&P500 52-Week Change 323.76%
52 Week High 32.7200
52 Week Low 32.1000
50-Day Moving Average 32.4496
200-Day Moving Average 32.3864

Share Statistics

Avg Vol (3 month) 39
Avg Vol (10 day) 3N/A
Shares Outstanding 5219.9M
Implied Shares Outstanding 62.56B
Float 8875.33M
% Held by Insiders 10.00%
% Held by Institutions 129.78%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.1
Forward Annual Dividend Yield 44.02%
Trailing Annual Dividend Rate 30.75
Trailing Annual Dividend Yield 331.21%
5 Year Average Dividend Yield 43.25
Payout Ratio 429.78%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 13, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 5.34%
Operating Margin (ttm)10.12%

Management Effectiveness

Return on Assets (ttm)3.82%
Return on Equity (ttm)11.63%

Income Statement

Revenue (ttm)76.83B
Revenue Per Share (ttm)47.25
Quarterly Revenue Growth (yoy)6.10%
Gross Profit (ttm)N/A
EBITDA 5.29B
Net Income Avi to Common (ttm)4.11B
Diluted EPS (ttm)0.3300
Quarterly Earnings Growth (yoy)2.60%

Balance Sheet

Total Cash (mrq)19.76B
Total Cash Per Share (mrq)12.15
Total Debt (mrq)13.8B
Total Debt/Equity (mrq)35.66%
Current Ratio (mrq)1.64
Book Value Per Share (mrq)22.67

Cash Flow Statement

Operating Cash Flow (ttm)3.8B
Levered Free Cash Flow (ttm)1.64B